Boston Scientific
BSX
BSX
556 hedge funds and large institutions have $34.8B invested in Boston Scientific in 2017 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 209 increasing their positions, 203 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3% more repeat investments, than reductions
Existing positions increased: 209 | Existing positions reduced: 203
0.93% less ownership
Funds ownership: 92.59% → 91.66% (-0.93%)
9% less funds holding in top 10
Funds holding in top 10: 11 → 10 (-1)
Holders
556
Holding in Top 10
10
Calls
$65M
Puts
$43.8M
Top Buyers
| 1 | +$1.07B | |
| 2 | +$237M | |
| 3 | +$123M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$85.5M |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
+$84.1M |
Top Sellers
| 1 | -$289M | |
| 2 | -$161M | |
| 3 | -$161M | |
| 4 |
AIM
abrdn Investment Management
Edinburgh,
United Kingdom
|
-$119M |
| 5 |
Millennium Management
New York
|
-$116M |